PG
BIO icon

Pendal Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Pendal Group’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,096
Closed -$617K – 461
2022
Q1 		$617K Buy
+1,096
New +$661K 0.01% 383
2020
Q4 		– Sell
-526
Closed -$271K – 512
2020
Q3 		$271K Sell
526
-1,147
-69% -$581K ﹤0.01% 371
2020
Q2 		$755K Buy
1,673
+1,062
+174% +$469K 0.01% 268
2020
Q1 		$214K Buy
611
+372
+156% +$137K ﹤0.01% 333
2019
Q4 		$88.4K Buy
+239
New +$84.3K ﹤0.01% 398

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return